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Abstract
Background: Colorectal cancer (CRC) is the second leading cause of cancer death in the United States, and
endoscopic screening can both detect and prevent cancer, but utilization is suboptimal and varies across
geographic regions. We use multilevel regression to examine the various predictors of individuals’ decisions to
utilize endoscopic CRC screening. Study subjects are a 100% population cohort of Medicare beneficiaries identified
in 2001 and followed through 2005. The outcome variable is a binary indicator of any sigmoidoscopy or
colonoscopy use over this period. We analyze each state separately and map the findings for all states together to
reveal patterns in the observed heterogeneity across states.
Results: We estimate a fully adjusted model for each state, based on a comprehensive socio-ecological model. We
focus the discussion on the independent contributions of each of three community contextual variables that are
amenable to policy intervention. Prevalence of Medicare managed care in one’s neighborhood was associated with
lower probability of screening in 12 states and higher probability in 19 states. Prevalence of poor English language
ability among elders in one’s neighborhood was associated with lower probability of screening in 15 states and
higher probability in 6 states. Prevalence of poverty in one’s neighborhood was associated with lower probability
of screening in 36 states and higher probability in 5 states.
Conclusions: There are considerable differences across states in the socio-ecological context of CRC screening by
endoscopy, suggesting that the current decentralized configuration of state-specific comprehensive cancer control
programs is well suited to respond to the observed heterogeneity. We find that interventions to mediate language
barriers are more critically needed in some states than in others. Medicare managed care penetration,
hypothesized to affect information about and diffusion of new endoscopic technologies, has a positive association
in only a minority of states. This suggests that managed care plans’ promotion of this cost-increasing technology
has been rather limited. Area poverty has a negative impact in the vast majority of states, but is positive in five
states, suggesting there are some effective cancer control policies in place targeting the poor with supplemental
resources promoting CRC screening.
Background
Colorectal cancer (CRC) is the third most common can-
cer in both men and women, accounting for 10% of all
new cancers and 9% of cancer deaths for each [1]. CRC
can be detected through endoscopic screening, and sur-
vival rates are 90% if diagnosed early. Endoscopic
screening can also prevent CRC by detecting and
removing precancerous lesions as part of the screening
procedure. However, CRC screening rates remain low,
as only 42.2% of the over-50 population received any
type of CRC screening within the past 5 years [2]. Only
39% of CRC cases are diagnosed at an early stage, and
CRC remains the second leading cause of cancer death
in the United States [3-6]. CRC incidence is 15 times
greater among persons aged 65+ than among younger
populations [7]. This is important because the popula-
tion cohort size and life expectancy of older persons
c o n t i n u e st oi n c r e a s e[ 8 , 9 ] .T h u s ,t h ec o m o r b i d i t ya n d
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expected to increase unless enhanced understanding of
factors associated with screening uptake can be used to
effectively promote screening and early-stage cancer
diagnosis.
Endoscopic CRC screening and diagnostic follow-up
are cost-effective strategies in the prevention of CRC
[10-12]. This means that society values the benefits of
CRC screening in terms of reduced morbidity and mor-
tality burdens and is willing to pay the price of screen-
ing. Sigmoidoscopy, which observes only the lower
p o r t i o no ft h ec o l o n ,m a yb em o r ec o s t - e f f e c t i v et h a n
colonoscopy because of large differences in cost. Both
procedures are quite effective at detecting cancer or
detecting and removing precancerous lesions, thus pre-
venting CRC from progressing. However, colonoscopy is
more clinically effective at detecting precancerous
lesions, because it observes the entire (upper and lower)
colon. As costs of chemotherapy rise with the adoption
of new drugs [13] or as guidelines for repeat colono-
scopy are updated to recommend longer periods
between exams [10], colonoscopy becomes even more
cost-effective, even cost-saving over the patient’s
lifetime.
The cost-effectiveness of endoscopy for CRC screening
has resulted in coverage for the elderly under traditional
Medicare insurance. Medicare fee-for-service (FFS) is
the traditional Medicare insurance available for persons
aged 65+ who have earned enough work credits to qua-
lify for Social Security benefits. Part A coverage for hos-
pitalization is available for all as a Social Security
benefit, but Part B coverage (for outpatient care)
requires payment of a premium (about $360 per
month). Traditional Medicare FFS coverage is usually
defined to include both Parts A and B coverage; we use
this definition in this paper. Traditional Medicare FFS
coverage has been consistent with CRC screening guide-
lines. Since 1998, Medicare FFS has covered sigmoido-
scopy every 4 years for all persons over age 50 and
colonoscopy every 2 years for persons at high risk for
CRC. In 2001, most guidelines suggested that people
over age 50 should receive an annual fecal occult blood
test (FOBT) or fecal immunochemical test (FIT), peri-
odic sigmoidoscopy, or a combination of FOBT/FIT and
sigmoidoscopy. Many organizations also recommended
screening average-risk persons with colonoscopy every
10 years. With benefits expansion in 2001, FFS Medicare
now covers colonoscopy every 10 years for persons of
average risk; however, there is considerable geographic
variation in screening uptake [14,15].
Medicare can expect to cover most older individuals
for their remaining life spans and can thus recoup the
financial benefits from covering the service. By contrast,
the financial benefits from promoting a cost-effective
screening technology may not accrue to Medicare man-
aged care insurance plans if enrollees do not remain
enrolled for a long period of time in the plan. This may
reduce the likelihood that the managed care plan will
promote use of the service or recommend use concor-
dant with established guidelines [16].
Elderly persons have the option of either enrolling in
traditional Medicare or in one of several managed care
plans provided by private insurance companies, known
as Medicare managed care (MMC) plans. Nationally
representative evidence suggests that MMC enrollees
were more likely to use the much less costly FOBT pro-
cedure than endoscopic procedures for CRC screening,
as compared to FFS Medicare enrollees [17]. FOBT can
detect cancers that are already established in the bowel
and is much less expensive than the more clinically
effective endoscopic procedures, which have the added
benefit of identifying and removing precancerous
lesions. Current guidelines recommend using a combi-
nation of FOBT or the newer FIT [18] and endoscopy
[19]. We focus on endoscopy use in this paper because
Medicare claims accurately capture these services but do
not accurately capture all FOBT/FIT test use, and
because recent evidence suggests that FOBT/FIT tests
are rarely used properly [20].
Managed Care Spillover Effects
Endoscopic CRC screening is a cost-increasing technol-
ogy, relative to use of FOBT/FIT alone. When managed
care penetrates the health care market, it may impact
diffusion of new cost-increasing technologies and the
practice patterns of providers in the area, a phenom-
enon known as managed care spillover effects.T h e s e
effects have been shown to spill over onto constituents
who are not enrolled in the managed care plans, such as
traditional Medicare enrollees [21]. Our study subjects
are traditional Medicare enrollees, and we expect there
may be spillovers on their behaviors as follows. Changes
in practice patterns can spill over to people who are not
insured by the managed care plans, but who are seen by
the physicians who are affected by the information or
guidelines the plans disseminate. Also, traditional Medi-
care insured people may compare treatment options and
be influenced by the care patterns received by their
peers who are in MMC plans. When peers are in mana-
ged care plans, their available treatment options may
influence their neighbors who are not in managed care
plans. Thus, elderly persons with traditional Medicare,
living in neighborhoods where many peers are enrolled
in MMC plans, may be influenced by the managed care
plan enrollees, causing a behavioral spillover. Thus, if
MMC plans favor use of FOBT over endoscopy, we
m i g h te x p e c tt os e en e g a t i v es p i l l o v e r sf r o mM M C
penetration on FFS beneficiary use of endoscopy. Two
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samples of Medicare FFS beneficiaries in different time
periods find contradictory evidence regarding MMC
spillover effects [22,23]. Koroukian et al. [23] concluded
that there could be modest MMC spillovers that
improve use of endoscopic CRC screening, based on
1999 data covering the traditional Medicare population
in the largest US counties. Mobley et al. [22] found that
spillovers were positive in some states and negative in
others, using 2000-2005 data for 11 states and a 5%
sample of Medicare FFS enrollees.
The literature suggests that utilization of CRC screen-
ing varies widely across geographic areas [14,24-33]. No
study to date has examined the entire FFS Medicare
population over a period following the 2001 Medicare
coverage expansion to include colonoscopy (in addition
to sigmoidoscopy), which is a major contribution of this
paper. We find considerable variation in our 100% FFS
Medicare population screening rates among the states,
as shown in Figure 1. The proportions of the population
with any use in the 5-year period range from 44+% in
Maryland, Minnesota, Delaware and Florida to less than
37% in nine states, with the lowest rate of 34% in New
Mexico.
Rates of provider reimbursement for endoscopic proce-
dures vary considerably across insurance types and loca-
tions [25-28]. With no consensus regarding which
screening protocol is best, local practice patterns may
evolve that reflect local insurance reimbursement rates,
local physician specialties or capital investments, and
managed care practices that spill over onto other sectors,
leading to geographic disparities in the type and rate of
CRC test utilization [14,22]. Given these market influ-
ences, several recent studies have highlighted the need to
assess the capacity available to perform endoscopic sur-
veillance to detect CRC [26,29-35]. Because managed
care penetration and endoscopic capacity varies so much
across the country, and managed care spillovers can
impact the diffusion of new cost-increasing technology
(endoscopy versus FOBT/FIT), geographic differences in
availability of endoscopic services are likely to persist.
Results
Our modeling is based on a socio-ecological model
describing a comprehensive set of predictors of CRC
screening at multiple levels, including personal, social
community, health system, and state (Figure 2). The
conceptual model situates the individual decision maker
into an ecological context that has personal, socio-
demographic, and health system factors that interact
spatially to influence health utilization behavior.
We define the health system factors at the county
level, and these include capacity factors (availability of
endoscopy facilities, gastroenterologists, and oncologists)
and market factors impacting diffusion dynamics
(e.g., MMC penetration, area poverty). The socio-
demographic factors are defined for smaller areas
known as primary care service areas (PCSA), which
were formed from the aggregation of ZIP code tabula-
tion areas to reflect Medicare patient travel to primary
care providers [36]. PCSAs are smaller than counties
and are thought to better represent local neighborhood
conditions [37]. Spatial interaction along the pathways
to health care utilization is impacted by socio-demo-
graphic factors, including English language ability
among the elderly or residential segregation by race or
ethnicity; and transportation factors, such as commuter
intensity in the local PCSA. Other personal enabling or
Figure 1 Utilization Rates for Endoscopy. Proportion of the 100%
Medicare fee-for-service (FFS) population cohort, defined in 2001,
who ever utilized endoscopic screening for colorectal cancer during
2001-2005.
Figure 2 Socio-Ecological Model. Socio-ecological model of
factors impacting probability of endoscopic colorectal cancer
screening.
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distance to the closest endoscopy provider and whether
the person has recently moved to a new ZIP code of
residence (see Table 1, which describes the variables
and their original sources; many are now available
online at the public use RTI Spatial Impact Factor Data-
base Web site: http://rtispatialdata.rti.org).
Using this conceptualization, we estimate a binary pro-
bit model of individual screening behavior separately for
each state’s Medicare FFS population. Because endo-
scopic screening is not recommended annually, we define
a cohort in 2001 and follow them through 2005 and
determine utilization over this 5-year interval. Holding
constant statistically the many factors associated with
CRC screening utilization, we isolate the independent
effects of three contextual variables amenable to policy
intervention: MMC spillovers, elderly English language
ability, and poverty in the individual’s residential neigh-
borhood. We answer the following research questions:
1. Are there significant MMC spillover effects? How
do these vary across states?
2. Are there significant elderly language ability effects?
How do these vary across states?
3. Are there significant area poverty effects? How do
these vary across states?
MMC penetration in one’s residential neighborhood
and English language ability among the elderly are
thought to impact the information flows among seniors.
Higher MMC penetration is expected to be associated
with larger managed care spillover effects, which could
be either positive (increasing screening utilization) or
negative, depending on whether managed care spillovers
slow the diffusion of the new cost-increasing technology
or promote it. Living in a community with poorer Eng-
lish language ability among the elderly is expected to
lower the probability of utilization, unless the foreign
cultural community has undertaken promotional activ-
ities to promote CRC screening. We also focus on a
third variable, area poverty, which is expected to affect
both the supply of and demand for CRC screening. We
anticipate that seniors living in more impoverished
neighborhoods will have lower probability of utilization.
Even though our study population is insured by tradi-
tional Medicare for endoscopic procedures, there are
out-of-pocket costs (about $25 for sigmoidoscopy and
about $250 for colonoscopy) that may be substantial for
Table 1 Variables Used in Multilevel Regression Analysis
Characteristic of Sample Population Data Source
Enabling/Disabling Developed from CMS Medicare 100% Denominator Files, 2001-2005,
and calculations performed using geocoded data and distance
algorithms
Moved to a new ZIP code in same state, 2001-2005
Months with extra assistance from state Medicaid to purchase Part B
insurance, 2001-2005
Distance (miles) to closest endoscopy facility
Predisposing
Age in 2001
Gender; race or ethnicity
Socio-Demographic Factors (PCSA area)
Social Integration and Support: Segregation (isolation) index describing
residential segregation by race or ethnicity, following Massey and Denton
[52]
Developed from US Census 2000 data at ZCTA levels aggregated to
PCSAs using ZCTA-PCSA crosswalk: http://rtispatialdata.rti.org
Stressor, Driver Courtesy: Commuter intensity reflecting the proportion of
the workforce commuting 60 minutes or more each way to work
Social or Cultural Cohesion: Proportion of the population aged 65+ with
little or no English language ability, 2000
Health System Factors (County area)
Capacity: Average number of endoscopy facilities per thousand population
aged 65+ in each person’s residential area, defined in 2001
Providers identified from CMS Medicare outpatient claims files; annual
census population
Capacity: Number of oncologists or per thousand population aged 65+,
defined in 2001
Area Resource File and annual census population
Market factor: MMC plan penetration, defined in 1998 CMS Geographic Service Area File
Market stressors: Proportion of population living below the federal poverty
level in 2001; proportion of the county that is rural
Census annual poverty and population
Note: MMC = Medicare managed care; ZCTA = ZIP Code Tabulation Area; HRSA = Health Resources and Services Administration; PCSA = Primary Care Service
Area; CMS = Centers for Medicare & Medicaid Services.
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cation, we control at the personal level for elderly who
meet the low-income threshold and qualify to receive
subsidies from state Medicaid programs to cover their
Part B premiums (but subsidies do not cover procedure
co-payments). These low-income elderly are dually eligi-
ble for Medicare and Medicaid, as they receive benefits
from both programs. Holding this dual eligibility indica-
tor variable constant statistically, we still expect to find
a significant neighborhood poverty effect. Elderly living
in poor neighborhoods are expected to have worse
access to endoscopy providers and to be less financially
secure and less willing to pay the required co-payments
for endoscopy services.
The results for these three policy variables are sum-
marized in a series of maps of the 50 states. Each map
represents a single policy covariate, colored to reflect
positive, negative, or no significant association. We
expect differences across states, which would reinforce
the current practice of decentralized comprehensive
cancer control efforts, whereby each state has consider-
able autonomy to decide what goals and policies to pur-
sue [38,39].
Study Population
We define a cohort of persons aged 65+ in 2001 with
both Parts A and B Medicare for the entire period
2001-2005, and we follow these individuals over time,
using 100% Medicare claims annually to record any
endoscopy use by persons. Persons included in the
cohort must remain alive during the entire period and
remain living in the same state. Table 2 provides sample
statistics by state, where the number of cohort observa-
tions per state is reported. The smallest cohort is in
Alaska (22,585 individuals) and the largest is in Florida
(1,139,258).
Statistical Analysis
The outcome of interest is endoscopic procedure utiliza-
tion by our sample cohorts, identified from their Medi-
care claims. Any type or amount of endoscopic
procedure use over the 5-year period was used to define
a binary indicator to use as the outcome variable for
each person. We estimate a fully adjusted multilevel
probit regression model of individual screening behavior,
which includes individual-level demographic variables;
local neighborhood variables, including poverty, residen-
tial segregation, and English language ability among the
elderly; and county-level health care system factors,
such as MMC penetration, provider density, and dis-
tance to closest endoscopy provider (see Table 1 for
variables included in modeling). Recognizing that indivi-
dual state’s comprehensive cancer control efforts, politi-
cal, and regulatory environments are unique, we
examine states separately. Because MMC plans may
have used federal subsidies to enter riskier markets
where elderly had lower coverage rates for Part B Medi-
care during this period [40,41], we expect that there
may be a contemporaneous negative association between
MMC penetration and area endoscopy utilization rates.
Thus, we lag the managed care penetration variable 3
years (using 1998 data to predict 2001-2005 utilization)
to reduce the potential for endogeneity caused by this
sort of market selection by the MMC plans.
We used generalized estimating equations (GEE) to
adjust the standard errors of area-level variables to
reduce the bias caused by repeated measures for all peo-
ple in an area. The GEE approach is appropriate when
the outcome variable is binary and when researchers are
concerned with estimating population-level effects
(rather than community-specific effects) [42-44]. The
estimated regression slope parameters, estimating the
association between explanatory and outcome variable,
are interpreted as marginal probability impacts. The
estimate 0.05 on covariate X, for example, is interpreted
as follows: a small increase in covariate × is associated
with a 5% increase in the probability of endoscopic CRC
screening utilization in the state population, on average,
holding all other covariates constant statistically.
Estimating a separate regression for each of the 50
states resulted in a large volume of empirical findings.
We translate the particular findings of interest using
three maps of the United States to depict the slope
parameter estimates for the three covariates of central
f o c u s( F i g u r e s3 ,4 ,a n d5 ) .T h em a p sd i s p l a y5 0s l o p e
parameter estimates for each covariate, because there is
a separate estimate for each state. When the estimated
slope parameter is not significantly different from zero,
it is represented as zero/no effect. Using this innovative
format for spatial translation of the research findings
allows the large volume of findings to be condensed to
manageable subsets that can be compared visually across
the states.
Discussion
We focus on the findings relevant to the three main
research questions posed above and present these gra-
phically using maps of the United States. In answer to
the first research question, we find that there are signifi-
cant MMC spillover effects and that these do vary
a c r o s st h es t a t e s( s e eF i g u r e3 ) .T h ef i n d i n g sp r e s e n t e d
here based on the 100% Medicare FFS population pro-
vide the first evidence to date for the entire Medicare
population following benefits expansion in 2001 to
cover colonoscopy. Prevalence of MMC in one’sn e i g h -
borhood was associated with lower probability of screen-
ing in 12 states (negative spillover on the FFS
population) and higher probability in 19 states (positive
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Consistent with our theory regarding managed care plan
promotion of endoscopy dependent on ability to recoup
financial benefits, we find that the state with the largest
positive spillover effect (5.6% higher probability of
screening in more penetrated markets) is Hawaii. Hawaii
has had nearly universal employer-mandated health
insurance since 1974. In Hawaii, 48% of the insured
population was in managed care (health maintenance
organization [HMO]) plans in 2008, ranking as the top
state in terms of managed care penetration (see
Table 3). In this state, managed care plans are more
likely to be able to reap the benefits in terms of cost
savings for cost-effective technologies because long-term
enrollment in the plan is more likely under the
employer-mandated system. Also, with few people unin-
sured, Hawaii’s health care costs per person are lower
than any other state’s because the population receives
timely preventive care services [45]. Thus, it is not
surprising that the estimated MMC spillover effect is
the largest and most positive for this state. Several other
states with positive spillovers have also had historically
high managed care penetration, indicating acceptance of
the managed care model by their state populations,
m o s tn o t a b l yC a l i f o r n i a( s e eT a b l e3 ) .H o w e v e r ,n o ta l l
states with positive spillovers show a long history of
managed care acceptance.
In answer to the second research question, we find that
there are significant elderly language ability effects and
that these vary across the states. These effects are positive
in 6 states (Louisiana, Maine, Vermont, Washington,
Wisconsin, and Wyoming) and negative in 15 states
(Alaska, California, Florida, Hawaii, Illinois, Iowa, Michi-
gan, Montana, Nevada, New Hampshire, New Jersey,
New York, North Dakota, South Carolina, and Virginia)
(see Figure 4). These findings have implications for inter-
vention policies, which could target multilingual health
communication efforts to areas with lower English
Table 2 Cohort Size Used in Regression Models, and Number of PCSAs and Counties in Each of 50 States, and US
Totals
State Number of persons in
population cohort
Number of
PCSAs
Number of
counties
State Number of persons in
population cohort
Number of
PCSAs
Number of
counties
Alabama 319,335 144 67 Montana 79,539 71 56
Alaska 22,585 24 27 Nebraska 146,001 121 93
Arizona 223,305 74 15 Nevada 75,709 30 17
Arkansas 224,275 149 75 New
Hampshire
95,298 46 10
California 1,126,335 338 58 New Jersey 567,836 139 21
Colorado 156,466 96 63 New Mexico 100,328 61 33
Connecticut 245,186 71 8 New York 1,040,451 324 62
Delaware 64,072 12 3 North
Carolina
587,505 207 100
Florida 1,139,258 167 67 North Dakota 62,867 71 53
Georgia 464,828 169 159 Ohio 783,948 254 88
Hawaii 56,573 23 5 Oklahoma 248,870 156 77
Idaho 82,703 57 44 Oregon 151,816 78 36
Illinois 818,437 258 102 Pennsylvania 819,431 296 67
Indiana 471,278 172 92 Rhode Island 50,326 14 5
Iowa 274,939 225 99 South
Carolina
308,796 110 46
Kansas 211,602 162 105 South Dakota 72,116 95 66
Kentucky 307,484 145 120 Tennessee 395,590 145 95
Louisiana 244,130 112 64 Texas 1,118,495 414 254
Maine 121,387 91 16 Utah 113,066 54 29
Maryland 346,573 62 24 Vermont 50,631 49 14
Massachusetts 362,711 107 14 Virginia 492,814 170 128
Michigan 765,461 191 83 Washington 314,345 119 39
Minnesota 314,019 176 87 West Virginia 162,307 123 55
Mississippi 211,398 141 82 Wisconsin 412,030 173 72
Missouri 387,278 213 115 Wyoming 37,384 41 23
Total US 17,249,117 6,740 3,133
Note: PCSA = Primary Care Service Area.
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guage ability effects are negative, to boost endoscopic
CRC screening rates.
In answer to the third research question, we find that
there are significant area poverty effects and that these
vary across the states. Perhaps surprisingly, these effects
are positive in 5 states (California, Georgia, Iowa, Maine,
and New Mexico) (see Figure 5). They are not signifi-
cantly different from zero in 9 states and are signifi-
cantly negative in the remaining states. The positive
poverty effect noted for Georgia may be explained by
the fact that two Centers for Disease Control and Pre-
vention (CDC)- funded intervention projects to promote
CRC screening among low-income groups were imple-
mented in Georgia during our research period [38].
More recently, CDC has launched the Colorectal Cancer
Control Program (CRCCP), which provides funding to
22 states for 5 years. Under this funding program, local
comprehensive cancer control programs provide CRC
screening to low-income people aged 50 to 64 years
when no other payment option is available. Although
the CRCCP was not launched during our study period,
the remaining 4 states with a positive poverty coefficient
(California, Iowa, Maine, and New Mexico) are now par-
ticipants in this new program [46]. This suggests that
these states have been proactive in the comprehensive
cancer control planning as regards outreach to poor
people in their states.
Conclusions
The socio-ecological conceptual model used as the basis
for our empirical work (see Figure 1, Table 1) includes a
comprehensive set of multilevel factors that might
impact a person’s utilization of CRC screening. From a
statistical perspective, it is important to include a com-
prehensive set of covariates so that the independent
effects of several contextual factors of interest can be
assessed while holding other factors constant. We focus
on three community and health system factors here,
with particular focus on spillover effects from MMC
penetration on the FFS-insured individuals we study.
In a recent paper using 1999 data, Koroukian et al. [23]
analyzed CRC screening spillovers from MMC on the
FFS population in the 2,655 largest US counties. They
found consistently and significantly positive MMC pene-
tration spillovers on utilization of sigmoidoscopy alone
and colonoscopy following FOBT or sigmoidoscopy, but
no consistent findings for colonoscopy alone, the largest
utilization group, which is not surprising because Medi-
care benefits had not yet been expanded to cover colono-
scopy in 1999. Pooling all counties together, they
concluded that there could be modest MMC spillovers
that improve use of CRC screening by FFS enrollees.
Understanding and disentangling the mechanisms that
impact MMC spillovers is a complex endeavor, and prior
studies have indicated that there are numerous interact-
ing factors [47]. For instance, patient self-selection is an
essential aspect to consider when comparing patterns of
preventive care usage between the FFS and MMC
Figure 4 English Language Ability and Probability of
Endoscopic Colorectal Cancer Screening. Findings from state-
specific multivariate regressions: Associations between proportion
elderly with poor english language ability in one’s neighborhood
and probability of endoscopic colorectal cancer screening in the
100% Medicare fee-for-service (FFS) population cohort defined in
2001 and followed through 2005.
Figure 3 Medicare Managed Care (MMC) Penetration and
Probability of Endoscopic Colorectal Cancer Screening. Findings
from state-specific multivariate regressions: Associations between
Medicare managed care (MMC) penetration and probability of
endoscopic colorectal cancer screening in the 100% Medicare fee-
for-service (FFS) population cohort defined in 2001 and followed
through 2005.
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tion enrolled in a health plan may impact the patterns
and selection of screening tests [17,48].
Our paper is the first to use 100% Medicare popula-
tion data from all counties in 50 states to provide a defi-
nitive picture of MMC spillovers on FFS Medicare
insured individuals following expansion of benefits to
cover colonoscopy in 2001. We find that MMC spillover
effects are positive in more states than they are negative
(19 versus 12, respectively). Our findings may differ
from Koroukian et al. [23] for several reasons: differ-
ences in time period studied (1999 vs. 2001-2005), dif-
ferences in conceptual modeling, differences in the
geographic coverage of the studies, differences in the
treatment of spatial heterogeneity, and differences in
stability of the MMC market. In particular, Koroukian
et al. [23] examined only a subset of the largest US
counties, pooled together, whereas we include all coun-
ties and perform a truly 100% population analysis,
examining each state separately to reflect the heteroge-
neity inherent in decentralized state-run comprehensive
cancer control efforts.
We find that the largest positive MMC spillover
occurs in Hawaii. Hawaii is unusual in that it mandated
universal employer-provided insurance decades ago and
has very low uninsured population rates and the highest
HMO penetration rates in the country. Hawaii also
enjoys the lowest health care costs per capita, and our
findings suggest that managed care plans in this envir-
onment are able to reap the financial rewards from
promoting cost-increasing endoscopy technology that
reduces morbidity and mortality burdens.
Our evidence suggests negative MMC spillovers in 12
states (Colorado, Kentucky, Maine, Massachusetts,
Mississippi, New Jersey, North Carolina, South Dakota,
Vermont, Virginia, Washington, and Wisconsin). Nega-
tive spillovers are important for health policy because
they reflect detrimental health behavioral effects for per-
sons not insured by managed care, who live in areas
with greater managed care presence. Because CRC
screening is already lower than optimal, these findings
are of considerable policy importance.
Figure 5 Poverty and Probability of Endoscopic Colorectal
Cancer Screening. Findings from state-specific multivariate
regressions: Associations between poverty in one’s neighborhood
and probability of endoscopic colorectal cancer screening in the
100% Medicare fee-for-service (FFS) population cohort defined in
2001 and followed through 2005.
Table 3 Managed Care (HMO) Penetration of Insured
Population, by State, 1994-2008
State 1994 1998 2008 State 1994 1998 2008
Alaska 0.000 0.000 0.002 Montana 0.015 0.034 0.059
Alabama 0.100 0.107 0.041 North
Carolina
0.095 0.166 0.053
Arkansas 0.038 0.111 0.030 North
Dakota
0.083 0.029 0.026
Arizona 0.358 0.319 0.253 Nebraska 0.011 0.157 0.046
California 0.383 0.454 0.429 New
Hampshire
0.170 0.350 0.113
Colorado 0.244 0.354 0.196 New Jersey 0.169 0.340 0.208
Connecticut 0.274 0.377 0.215 New
Mexico
0.174 0.319 0.266
Delaware 0.205 0.344 0.192 Nevada 0.147 0.271 0.200
Florida 0.201 0.263 0.194 New York 0.243 0.363 0.277
Georgia 0.088 0.159 0.192 Ohio 0.192 0.225 0.179
Hawaii 0.232 0.320 0.477 Oklahoma 0.073 0.135 0.066
Iowa 0.041 0.099 0.075 Oregon 0.375 0.397 0.271
Idaho 0.012 0.082 0.046 Pennsylvania 0.215 0.351 0.280
Illinois 0.169 0.235 0.123 Rhode
Island
0.288 0.360 0.202
Indiana 0.074 0.161 0.170 South
Carolina
0.042 0.115 0.101
Kansas 0.109 0.150 0.147 South
Dakota
0.029 0.049 0.100
Kentucky 0.121 0.177 0.080 Tennessee 0.162 0.238 0.255
Louisiana 0.070 0.162 0.075 Texas 0.097 0.177 0.132
Massachusetts 0.352 0.502 0.343 Utah 0.192 0.348 0.296
Maryland 0.362 0.360 0.261 Virginia 0.084 0.210 0.163
Maine 0.062 0.238 0.094 Vermont 0.126 0.289 0.088
Michigan 0.202 0.248 0.277 Washington 0.164 0.283 0.186
Minnesota 0.266 0.306 0.213 Wisconsin 0.242 0.297 0.248
Missouri 0.147 0.268 0.132 West
Virginia
0.000 0.102 0.150
Mississippi 0.003 0.034 0.015 Wyoming 0.000 0.028 0.042
Note: Bold font indicates the 19 states with positive MMC spillovers shown in
Figure 3.
Italics font indicates the 12 states with negative MMC spillovers shown in
Figure 3.
Sources: (1994 and 1998 data) InterStudy, “The InterStudy Competitive Edge:
HMO Report,” St. Paul, Minnesota; (2008 data) Kaiser Family Foundation, State
Health Facts, retrieved June 15, 2010, from http://www.statehealthfacts.org/
comparemaptable.jsp?cat=7&ind=349.
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Page 8 of 11Our MMC spillover findings may be an artifact of the
time period studied. More research on MMC spillovers is
needed because this period was one of considerable tur-
moil in MMC markets. Following the Balanced Budget
Act of 1997, many MMC plans withdrew from certain
counties where profit margins were thin, leaving former
plan members involuntarily disenrolled [40]. Then, in
2003, the Medicare Modernization Act promoted new
demonstration plans in some states with limited drug
coverage to re-stimulate interest in MMC plans among
the elderly, which had limited success [41]. Future analy-
sis from 2006 forward will be enlightening, as the Part D
drug benefit was implemented and all MMC plans (now
called Medicare Advantage plans) were required to offer
drug coverage. This coverage expansion caused revived
interest in Medicare managed care plans among the
elderly. Drug coverage may relax the out-of-pocket con-
straints that face financially insecure elderly and promote
use of endoscopic procedures. Time will tell whether the
Medicare managed care spillover effects remain variable
over geography, or whether our findings were a symptom
of upheaval in the MMC plan market.
We attempted to include relevant variables at the indi-
vidual, neighborhood, and health system levels in the
multivariate regressions. Although we do have informa-
tion regarding eligibility for state assistance paying Part
B premiums (which is available for low-income seniors),
not all low-income seniors apply for this. Socioeconomic
status at the individual Medicare beneficiary level was
not available, and this is a potential limitation of the
analysis. Also, colonoscopy is recommended every 10
years for older persons of average risk [19]. However,
our study examines the screening behavior of the Medi-
care population for 5 years (2001-2005) following the
expansion of benefits to cover colonoscopy. It is likely
that some of the population being studied received
endoscopic screening prior to 2001 or after 2005.
Because we examine a 5-year time window, our findings
may underestimate the proportion of persons utilizing
endoscopy commensurate with established guidelines. In
addition, the Medicare Modernization Act of 2003 could
have introduced changes in MMC screening practices
and their spillovers midway through the study period.
Finally, we lagged the MMC penetration variable by 3
years to avoid potential endogeneity caused by plan
selection of certain types of markets for entry, and this
may have introduced measurement error, as MMC
penetration rates were declining in many counties dur-
ing the study period.
Despite these limitations, this paper provides impor-
tant evidence to inform the ongoing debate regarding
health care market reform in the United States. Our
findings demonstrate that access to and utilization of
endoscopic CRC screening, even among a well-insured
elderly population, depends on community-level social
determinants (such as English language ability among
the elderly) in addition to market factors (area poverty,
which drives both supply and demand for endoscopy;
and spillover effects from managed care). Of policy
importance, contextual variables like these can be used
to target communities in greatest need of health care
interventions to reduce information problems or poten-
tial cultural or financial barriers in order to improve uti-
lization of technology that can both detect and prevent
CRC. Thus, the importance of space and place is not
only of scientific interest, but is also central to the effec-
tive design of policies, as reflected in the August 11,
2009, White House Memorandum on “Developing Effec-
tive Place-Based Policies for the FY-2011 Budget” [49].
This study confirms recent findings regarding barriers
and facilitators to endoscopy utilization by older per-
sons, such as having dual coverage of Medicare and
Medicaid, being female, being African American or His-
panic [50], and living in rural versus urban areas [51].
This is the first study to date to examine the socio-
ecological context of endoscopy utilization in the entire
Medicare FFS population, providing information that is
actionable for interventions that are as heterogeneous as
their state environments.
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